| Literature DB >> 33505936 |
Song Min Lee1, Hee Sook Kim1, Hye-Jung Park1, Ka-Yoon Oh1, Ji-Youn Kim1, Sang-Hyeon Lee2, Jeong Su Jang1, Mun Hyon Lee1.
Abstract
This study proposes the processing method that could maximize the functional properties of evening primrose seeds (EPS) and its various nutritional components. EPS can be prepared by different methods, such as being left raw, roasting, steaming, and powdering. Processing of EPS to create EPS powder (EPSP) resulted in higher levels of vitamin E, fatty acids, total phenolic contents, and antioxidant activity, compared with the other processing methods. Also, EPSP maintained lipid peroxidation inhibitory activity for 49 days. In particular, the EPSP ethyl acetate (EtOAc) fraction exhibited high antioxidant, antidiabetic, and angiotensin I-converting enzyme inhibitory activities. The EPSP ethyl acetate fraction showed a high cytoprotective effect against H2O2-induced cell damage in both RAW264.7 and EA.hy926 cells. In addition, the EtOAc fraction showed anti-inflammatory activity by the inhibitory activity of nitric oxide (NO) in RAW264.7 cells, and antihypertensive activity by the activity of NO in EA.hy926 cells. These results suggest that EPSP could be useful as a food ingredient that assists the prevention of various diseases caused by oxidative stress.Entities:
Keywords: anti-inflammation; antihypertension; cytoprotective effect; evening primrose seed powder; processing methods
Year: 2020 PMID: 33505936 PMCID: PMC7813601 DOI: 10.3746/pnf.2020.25.4.422
Source DB: PubMed Journal: Prev Nutr Food Sci ISSN: 2287-1098
Fig. 1Images of the equipment and samples used in this study. All extract housing except grinding housing had a round hole of a different size on the surface. The grinding housing has a large square hole at the bottom. The fruit housing, standard housing and grinding housing produced powdered samples. The multi-housing produced a powder-oil sample, with the arrow indicating oil in the powder-oil mixed sample.
Fig. 2Phenolic contents and antioxidant activity of evening primrose seeds by processing method. (A) Total phenolic contents, (B) 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity, and (C) 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) radical scavenging activity. Values are mean±SD (n=3). Different letters (a-i) indicate significant differences among samples (P<0.05), as calculated by Duncan’s multiple range test.
Vitamin E contents, fatty acid compositions, and antioxidant activities of evening primrose seeds by processing method
| Evening primrose seeds | ||||
|---|---|---|---|---|
| Raw | Roasting | Steaming | Powder | |
| Vitamin E (mg/100 g) | ||||
| α-tocopherol | 35.26±0.02[ | 34.60±0.32[ | 35.25±1.07[ | 36.55±0.61[ |
| β-tocopherol | 0.76±0.08[ | 0.76±0.04[ | 0.81±0.02[ | 1.00±0.07[ |
| γ-tocopehrol | 52.97±3.33 | 53.57±1.38 | 54.35±0.35 | 56.32±2.11 |
| δ-tocopehrol | 1.21±0.04[ | 1.24±0.03[ | 1.27±0.03[ | 1.34±0.03[ |
| Fatty acid (g/100 g) | ||||
| Palmitic acid (C16:0) | 0.697±0.005 | 1.051±0.020 | 1.038±0.003 | 1.171±0.017 |
| Palmitoleic acid (C16:1) | 0.005±0.000 | 0.008±0.000 | 0.008±0.000 | 0.009±0.000 |
| Stearic acid (C18:0) | 0.194±0.004 | 0.297±0.004 | 0.294±0.001 | 0.330±0.001 |
| Oleic acid (C18:1, Cis) | 0.791±0.005 | 1.182±0.019 | 1.150±0.010 | 1.308±0.008 |
| Linoleic acid (C18:2, Cis) | 7.500±0.081 | 11.388±0.122 | 11.233±0.068 | 12.599±0.078 |
| Linolenic acid (C18:3n-3) | 0.016±0.000 | 0.025±0.001 | 0.024±0.000 | 0.029±0.001 |
| g-Linolenic acid (C18:3n-6) | 0.938±0.014 | 1.448±0.011 | 1.435±0.006 | 1.605±0.010 |
| Arachidic acid (C20:0) | 0.041±0.001 | 0.061±0.001 | 0.062±0.001 | 0.069±0.001 |
| Gadoleic acid (C20:1) | 0.021±0.001 | 0.033±0.001 | 0.033±0.001 | 0.037±0.001 |
| Heneicosanoic acid (C20:2) | 0.009±0.001 | 0.015±0.001 | 0.014±0.000 | 0.016±0.001 |
| Eicosadienoic acid (C22:0) | 0.026±0.000 | 0.036±0.001 | 0.039±0.001 | 0.042±0.002 |
| Lignoceric acid (C24:0) | 0.015±0.000 | 0.021±0.000 | 0.023±0.000 | 0.025±0.001 |
| Saturated fatty acid | 0.972±0.009[ | 1.465±0.026[ | 1.456±0.002[ | 1.638±0.005[ |
| Unsaturated fatty acid | 9.281±0.094[ | 14.098±0.154[ | 13.887±0.083[ | 15.603±0.097[ |
| Total fatty acid | 10.253±0.102[ | 15.563±0.179[ | 15.342±0.084[ | 17.240±0.102[ |
| Anti-oxidant activity | ||||
| TPC (mg GAE/g) | 206.41±4.40[ | 221.52±2.27[ | 205.36±2.85[ | 229.64±5.99[ |
| TFC (mg QE/g) | 88.56±13.96[ | 121.83±2.20[ | 85.61±2.27[ | 139.46±7.52[ |
| TPCC (mg/g) | 77.80±2.52[ | 92.72±5.44[ | 80.28±4.25[ | 97.21±3.08[ |
| DPPH radical scavenging (IC50 value) | 36.38±2.83[ | 34.13±1.45[ | 35.23±1.73[ | 28.05±2.19[ |
| ABTS radical scavenging (IC50 value) | 117.04±8.32[ | 69.49±3.37[ | 75.37±3.02[ | 64.83±4.10[ |
Mean±SD (n=3).
Means with different letters (a-d) within a row are significantly different (P<0.05), as calculated by Duncan’s multiple range test.
TPC, total phenolic content; GAE, gallic acid equivalents; TFC, total flavonoid content; QE, quercetin equivalents; TPCC, total proanthocyanidin content; DPPH, 2,2-diphenyl-1-picrylhydrazyl; ABTS, 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt.
Fig. 3Lipid peroxidation inhibitory activity of evening primrose seed powder. Values are mean±SD (n=3). Different letters (a-c) indicate significant differences among samples (P<0.05), as calculated by Duncan’s multiple range test.
Antioxidant, anti-hypertensive, and anti-diabetic activities of solvent fractions of evening primrose seed powder
| Hexane | CH2Cl2 | EtOAc | BuOH | Water | ||
|---|---|---|---|---|---|---|
| TPC (mg GAE/g) | 43.33±0.15[ | 56.22±0.11[ | 868.88±7.58[ | 596.32±3.11[ | 612.02±4.80[ | |
| TFC (mg QE/g) | ND | ND | 429.89±7.13[ | 171.96±16.22[ | 221.63±15.56[ | |
| TPCC (mg/g) | ND | ND | 59.57±0.40[ | 31.82±0.35[ | 34.13±0.95[ | |
| ABTS radical scavenging (IC50 value) | 32,048.43±1,982.22[ | 1,363.14±154.12[ | 46.31±1.09[ | 124.98±1.85[ | 86.73±0.60[ | |
| DPPH radical scavenging (IC50 value) | 9,280.05±133.53[ | 594.63±20.16[ | 13.02±0.25[ | 29.97±1.38[ | 38.07±16.78[ | |
| Reducing power (μM FeSO4/g) | 5.97±0.41[ | 24.16±1.40[ | 96.96±1.74[ | 87.31±0.31[ | 84.14±2.77[ | |
| SOD-like activity (%) | 29.15±3.88[ | 74.53±0.48[ | 100.88±2.09[ | 97.79±0.68[ | 97.67±0.90[ | |
| α-Glucosidase | 10% | 84.56±3.45[ | 48.08±4.08[ | 99.12±1.29[ | 99.23±0.34[ | 98.99±0.09[ |
| inhibitory activity (%) | 50% | 96.06±3.11[ | 92.60±2.01[ | 93.75±2.86[ | 98.84±0.80[ | 100.01±1.59[ |
| 100% | 98.82±1.73[ | 97.39±1.31[ | 97.36±4.94[ | 97.92±0.57[ | 99.17±1.36[ | |
| α-Amylase | 10% | ND | ND | 19.72±1.01[ | 13.26±0.90[ | 7.25±1.00[ |
| inhibitory activity (%) | 50% | ND | ND | 53.34±1.90[ | 43.94±4.47[ | 39.39±3.16[ |
| 100% | ND | ND | 64.57±1.58[ | 55.44±4.29[ | 55.43±0.94[ | |
| PGG (μg/mg) | ND | ND | 237.82±5.84 | ND | ND | |
| ACE inhibitory activity (%) | 10.70±1.68[ | 10.20±0.64[ | 24.74±1.86[ | 3.88±0.55[ | 3.83±0.34[ | |
Mean±SD (n=3).
Means with the different letters (a-e) within a row are significantly different (P<0.05), as calculated by Duncan’s multiple range test.
ND, not detected.
TPC, total phenolic content; TFC, total flavonoid content; TPCC, total proanthocyanidin content; GAE, gallic acid equivalents; QE, quercetin equivalents; PGG, 1,2,3,4,6-penta-O-galloyl-β-D-glucose; DPPH, 2,2-diphenyl-1-picrylhydrazyl; ABTS, 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt; SOD, superoxide dismutase; ACE, angiotensin I-converting enzyme; CH2Cl2, dichloromethane; EtOAc, ethyl acetate; BuOH, butanol.
Fig. 4Cell cytotoxicity, cell protective activity and nitric oxide (NO) production induced by solvent fractions of evening primrose seed powder. Cell cytotoxicity in (A) RAW264.7 cells and (B) EA.hy926 cells. Cell protective activity against 10 mM H2O2 in (C) RAW264.7 cells and (D) EA.hy926 cells. NO production in (E) RAW264.7 cells and (F) EA.hy926 cells. CH2Cl2, dichloromethane; EtOAc, ethyl acetate; BuOH, butanol. Values are mean±SD (n=3). Significant differences among samples, as calculated by Student’s t-test. *P<0.05, **P<0.01, and ***P<0.001.